Literature DB >> 2969460

Can B cells turn on virgin T cells?

O Lassila1, O Vainio, P Matzinger.   

Abstract

The first event in the initiation of an immune response is the capture and presentation of antigen to T cells. Such presentation involves two distinct steps: (1) display of the antigen, which requires uptake, processing and re-expression of the antigen in association with MHC molecules on the presenting cell surface; and (2) triggering, in which the presenting cell provides signals leading to the activation of the responding T cell. Two sorts of cells can capture antigens, the 'professional' antigen-presenting cells (APCs) such as dendritic cells and macrophages, and the B cells. Both types of cells can display antigens and the APCs are known to be able to trigger resting T cells. But despite in vitro evidence that certain B-cell types can reactivate previously-activated T cells, it is not yet clear whether a B cell can initiate an immune response by providing the signals necessary to activate a resting T cell. We reasoned that resting B cells should not have this capacity because of the problems this would present with tolerance to self idiotypes. By exploiting the unique properties of the avian haematopoietic system, we have examined the presenting capacity of B cells in vivo and found that resting B cells are indeed unable to activate resting T cells.

Entities:  

Mesh:

Year:  1988        PMID: 2969460     DOI: 10.1038/334253a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  55 in total

1.  B cells and antibodies are required for resistance to the parasitic gastrointestinal nematode Trichuris muris.

Authors:  N M Blackwell; K J Else
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Identification of a B cell signature associated with renal transplant tolerance in humans.

Authors:  Kenneth A Newell; Adam Asare; Allan D Kirk; Trang D Gisler; Kasia Bourcier; Manikkam Suthanthiran; William J Burlingham; William H Marks; Ignacio Sanz; Robert I Lechler; Maria P Hernandez-Fuentes; Laurence A Turka; Vicki L Seyfert-Margolis
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

3.  Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching.

Authors:  Jason S Ellis; F Betul Guloglu; Habib Zaghouani
Journal:  Immunology       Date:  2016-01-28       Impact factor: 7.397

4.  Murine epidermal antigen-presenting cells in primary and secondary T-cell proliferative responses to herpes simplex virus in vitro.

Authors:  N A Williams; T J Hill; D C Hooper
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

5.  Antigen-specific T-T interactions regulate CD4 T-cell expansion.

Authors:  Julie Helft; Alexandra Jacquet; Nathalie T Joncker; Isabelle Grandjean; Guillaume Dorothée; Adrien Kissenpfennig; Bernard Malissen; Polly Matzinger; Olivier Lantz
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

Review 6.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

7.  Primary antigen-specific T-cell proliferative responses following presentation of soluble protein antigen by cells from the murine small intestine.

Authors:  N A Williams; A D Wilson; M Bailey; P W Bland; C R Stokes
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

8.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

9.  MHC class II-restricted T-cell hybridomas recognizing the nucleocapsid protein of avian coronavirus IBV.

Authors:  A M Boots; M J Van Lierop; J G Kusters; P J Van Kooten; B A Van der Zeijst; E J Hensen
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

10.  Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.

Authors:  M Benkerrou; D W Wara; M Elder; Y Dror; A Merino; B W Colombe; M Garovoy; M J Cowan
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.